We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.41B
AUM Growth
-$3.75B
Cap. Flow
-$4.09B
Cap. Flow %
-169.35%
Top 10 Hldgs %
31.78%
Holding
6,989
New
537
Increased
1,703
Reduced
3,620
Closed
686

Sector Composition

Rank Sector Weight
1 Technology 21.73%
2 Healthcare 7.71%
3 Consumer Discretionary 6.84%
4 Financials 6.55%
5 Industrials 4.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMI icon
3401
Badger Meter
BMI
$3.79B
$15K ﹤0.01%
135
-2,274
-94% -$247K
BOOT icon
3402
Boot Barn
BOOT
$4.95B
$15K ﹤0.01%
241
-3,658
-94% -$219K
CION icon
3403
CION Investment
CION
$370M
$15K ﹤0.01%
1,546
+140
+10% +$1.36K
DAIO icon
3404
Data I/O
DAIO
$32.4M
$15K ﹤0.01%
3,770
+2,113
+128% +$7.63K
DBB icon
3405
Invesco DB Base Metals Fund
DBB
$315M
$15K ﹤0.01%
766
+171
+29% +$3.28K
DBI icon
3406
Designer Brands
DBI
$299M
$15K ﹤0.01%
1,547
-5,423
-78% -$73.1K
DCO icon
3407
Ducommun
DCO
$3.13B
$15K ﹤0.01%
302
-9,461
-97% -$450K
DERM icon
3408
Journey Medical
DERM
$185M
$15K ﹤0.01%
7,633
+2,577
+51% +$5.1K
DNTH icon
3409
Dianthus Therapeutics
DNTH
$6.49B
$15K ﹤0.01%
2,426
+1,639
+208% +$29K
EFSC icon
3410
Enterprise Financial Services Corp
EFSC
$2.4B
$15K ﹤0.01%
307
-6,256
-95% -$311K
ENTA icon
3411
Enanta Pharmaceuticals
ENTA
$383M
$15K ﹤0.01%
335
-5,810
-95% -$265K
EPSN icon
3412
Epsilon Energy
EPSN
$169M
$15K ﹤0.01%
2,251
-1,013
-31% -$6.99K
EXPO icon
3413
Exponent
EXPO
$3.19B
$15K ﹤0.01%
151
-5,360
-97% -$521K
EYE icon
3414
National Vision
EYE
$1.53B
$15K ﹤0.01%
398
-6,320
-94% -$237K
GKOS icon
3415
Glaukos
GKOS
$10.9B
$15K ﹤0.01%
346
-5,384
-94% -$266K
HONE
3416
DELISTED
HarborOne Bancorp
HONE
$15K ﹤0.01%
1,134
-7,433
-87% -$106K
HOWL icon
3417
Werewolf Therapeutics
HOWL
$19.7M
$15K ﹤0.01%
7,146
+615
+9% +$1.61K
HTH icon
3418
Hilltop Holdings
HTH
$2.27B
$15K ﹤0.01%
508
-7,952
-94% -$226K
IESC icon
3419
IES Holdings
IESC
$15.1B
$15K ﹤0.01%
422
-442
-51% -$14.3K
INAB icon
3420
IN8bio
INAB
$10.8M
$15K ﹤0.01%
222
+161
+264% +$9.01K
INDO icon
3421
Indonesia Energy Corp
INDO
$45.9M
$15K ﹤0.01%
3,197
-1,203
-27% -$7.48K
INFY icon
3422
Infosys
INFY
$49B
$15K ﹤0.01%
814
-2,408
-75% -$44.8K
IWD icon
3423
iShares Russell 1000 Value ETF
IWD
$84.2B
$15K ﹤0.01%
100
-31,778
-100% -$4.76M
KALV
3424
DELISTED
KalVista Pharmaceuticals
KALV
$15K ﹤0.01%
2,292
+338
+17% +$1.81K
KN icon
3425
Knowles
KN
$3.29B
$15K ﹤0.01%
915
-12,294
-93% -$178K

Similar funds

Tower Research Capital (TRC)'s Q4 2022 Portfolio in Review

As of Q4 2022, Tower Research Capital (TRC) held 6,989 positions worth $2.41B, down 61% from $6.16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.09B in Q4 2022, closing 686 positions and reducing 3,620 holdings. Its most notable exit was Vanguard Russell 2000 Value ETF, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Semiconductor ETF worth $9.33M.

  • Tower Research Capital (TRC)'s largest Q4 2022 buy was iShares Semiconductor ETF: 80,454 shares worth $9.33M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2022, an estimated $145M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2022 reduction was Apple, cutting an estimated $322M.
  • Tower Research Capital (TRC) fully exited Vanguard Russell 2000 Value ETF in Q4 2022, selling an estimated $4.46M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $2.41B portfolio in Q4 2022.
  • Tower Research Capital (TRC) opened 537 new positions and closed 686 in Q4 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 61% quarter-over-quarter to $2.41B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.